COVID‐19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non‐malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement - The Medical Journal of Australia

Recommendations are based on evidence-based knowledge of safety, immunogenicity and efficacy of the vaccines in the general population, plus emerging data regarding COVID-19 vaccination in immunocompromised individuals

Following the recommendation for coronavirus disease 2019 (COVID19) vaccination in all children and adolescents aged 12 years and older, the Australian Technical Advisory Group on Immunisation (ATAGI… [+28271 chars]

full article...